We are advancing a pipeline of novel therapeutics for epilepsies, autism, and other CNS disorders.

close up of scientist recording and examining chemical tubs in l

science

Pushing the boundaries of neuroscience drug discovery

We couple emerging advances in neuroscience drug discovery and precision medicine for neuroscience to advance our pipeline of small molecule therapies for CNS disorders. Our therapies are designed to selectively inhibit clinically validated therapeutic targets and restore neuronal balance.

Working at IAMA therapeutics

We are a team of scientists, researchers, and biotech industry experts who value excellence, innovation, integrity, equality, respect for diversity, and the sustainability of our future generations.

latest news

13 Settembre 2023

IAMA Therapeutics to Present at Sachs Associates 23rd Annual Biotech in Europe Forum

GENOA, Italy, September 13, 2023 — IAMA Therapeutics, a pharmaceutical company focused on the discovery, development, and commercialization of novel medicines for children affected by brain […]

10 Luglio 2023

IAMA Therapeutics Announces Sponsored Research Agreement with The Sapienza University of Rome, Italy

GENOA, Italy, July 10, 2023 — IAMA Therapeutics, a pharmaceutical company focused on the discovery, development, and commercialization of novel medicines for children affected by brain […]

1 Giugno 2023

IAMA Therapeutics to Present at Upcoming BIO International Convention

GENOA, Italy, June 1, 2023 – IAMA Therapeutics, a preclinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel medicines to make a difference in […]